|
Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
 
|
3/2020
vol. 95 abstract:
Case report
Gordon syndrome in an 11-year-old boy: long-term follow-up
Andrzej Badeński
1
,
Marta Badeńska
1
,
Omar Bjanid
1
,
Justyna Czubilińska-Łada
1
,
Aleksandra Gliwińska
1
,
Anna Bogdał
2
,
Olga Kupczyk
3
,
Maria Szczepańska
1
1.
Chair and Department of Paediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
2.
Department of Paediatrics, District Hospital in Zawiercie, Poland
3.
Department of Paediatric Nephrology with Dialysis Division for Children, Independent Public Clinical Hospital No. 1, Zabrze, Poland
Pediatr Pol 2020; 95 (3): 184–190
Online publish date: 2020/10/30
View full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Gordon syndrome, or type 2 pseudohypoaldosteronism, is a rare familial occurring hypertension, in most cases inherited in an autosomal dominant manner. It is characterised by coexisting hyperkalaemia, which is not found in other monogenic forms of hypertension. In addition, in this syndrome aldosterone levels are usually low, and renin activity is reduced under normal salt loading. Renal function, assessed on the basis of glomerular filtration rate, is normal, but metabolic acidosis – type IV renal tubular acidosis – may occur. The authors would like to present the case of an 11-year-old boy in whom the above-described symptoms of Gordon syndrome were observed; clinically effective thiazide diuretic therapy, and subsequent genetic analysis confirmed the diagnosis.
keywords:
hyperkalaemia, renal tubular acidosis, pseudohypoaldosteronism type 2, monogenic arterial hypertension, rare genetic disease |
POLSKI
